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Abstract
We report a diabetic man with prior coronary artery bypass grafting 
(CABG) who underwent coronary angiography (CAG) because of medi-
cally refractory unstable angina. CAG revealed severe stenosis of the left 
circumflex artery (LCX) and the right coronary artery (RCA), patent artery 
graft to the left anterior descending artery and total occlusion of saphe-
nous venous grafts to the RCA and LCX. During percutaneous coronary 
intervention (PCI), the patient suffered from circulatory collapse. We post-
poned the procedure and placed an intra-aortic balloon pump (IABP); 
however, the patient remained hemodynamically unstable. He was res-
cued by PCI with extracorporeal membrane oxygenation (ECMO) support. 
No major cardiovascular event was reported during the 6-month follow-up 
period since treatment. We have learned that PCI in patients with prior 
CABG and severe left ventricular dysfunction has a high risk of inducing 
cardiogenic shock when an IABP is used. ECMO should be considered for 
these patients when PCI is performed on the vessels that supply only 
viable and contractile myocardium. [Tzu Chi Med J 2010;22(4):232–236]
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1. Introduction
Coronary artery bypass grafting (CABG) is the treat-
ment of choice for patients with diabetes and multi-
vessel coronary artery disease (CAD). The recurrence 
of angina pectoris in patients with prior CABG is usually 
due to atherosclerotic progression in native coronary 
arteries, bypass graft failure, or both. Repeat CABG 
and percutaneous coronary intervention (PCI) are the 
two available options for revascularization in this 
patient group. However, PCI and repeat CABG have 
several limitations and involve significant risks. 
Extracorporeal membrane oxygenation (ECMO) has 
been reported to provide full hemodynamic support 
in patients with a failing circulation. We report a male 
patient with prior CABG who received PCI. He suffered 
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circulatory collapse during the initial PCI and was 
subsequently completely revascularized with PCI under 
ECMO support.
2. Case report
A 51-year-old male patient with a previous history of 
hypertension, diabetes mellitus, uremia under regular 
hemodialysis, and peripheral artery occlusive disease 
had suffered from intermittent chest tightness for 
1 week. CABG had been performed 3 years earlier 
using the left internal mammary artery (LIMA) to the 
left anterior descending artery (LAD) and two saphe-
nous vein grafts (SVG) to the first obtuse marginal 
branch (OM1) and posterior descending artery. The 
patient had undergone regular follow-ups at an out-
patient clinic and was receiving medication, including 
aspirin, beta-blocker and lipid-lowering agents. Trans-
thoracic echocardiography showed global left ven-
tricular (LV) hypokinesis, with the exception of the 
inferoposterior segments, with a LV ejection fraction 
(LVEF) of 40%. Myocardial perfusion scan revealed 
anteroapical perfusion defect with minimal reversibil-
ity and reversible myocardial ischemia of the LV infero-
posterior wall, with an estimated LVEF of 30% at rest.
The patient was admitted to our institution because 
of medically refractory unstable angina. Coronary 
angiography (CAG) demonstrated patent LIMA to the 
LAD (Fig. 1A), total occlusion of both SVGs, 95% ste-
nosis of the proximal portion of the right coronary 
artery (RCA) (Fig. 1B), and 99% stenosis of the heavily 
calcified bifurcation lesions that involved the left cir-
cumflex artery (LCX) and its OM1 (Fig. 1C). The distal 
RCA branch received collateral supply from the LAD 
(Fig. 1D). We performed PCI to the LCX lesion, using a 
Runthrough floppy guidewire (Terumo Corp., Tokyo, 
Japan) to pass through the stenotic lesion. However, 
the patient began to experience severe substernal 
chest pain, dyspnea and nausea when we tried to pass 
through the OM1 lesion. Repeat contrast injection 
revealed thrombolysis in the Myocardial Infarction 
Grade 1 flow of the LCX and OM1 (Fig. 1D). Systolic 
blood pressure (SBP) dropped to 80 mmHg and heart 
Fig. 1 — Coronary angiography demonstrates: (A) patent left internal mammary artery to the left anterior descending 
artery (arrow); (B) severe stenosis of the right coronary artery; (C) critical bifurcation lesions involving the left circum-
flex artery and its first obtuse marginal branch (arrow); and (D) the distal right coronary artery branch receiving a col-
lateral supply from the left anterior descending artery (arrowhead), and acute closure of the first obtuse marginal branch 
when a wire was passed (arrow).
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rate increased from 82 to 110 bpm. Cardiogenic shock 
occurred and concomitant inotropic agents with an 
intra-aortic balloon pump (IABP) were used to stabilize 
the patient’s hemodynamics. PCI was postponed and 
the patient was sent to the intensive care unit.
Chest radiography demonstrated bilateral pul-
monary infiltrates, consistent with acute pulmonary 
edema. The patient’s SBP was approximately 95 mmHg, 
even with IABP support. Repeat CABG was judged to 
have a high perioperative mortality risk in these cir-
cumstances, and the feasibility of PCI under ECMO 
support was discussed. His family agreed to this treat-
ment strategy and provided informed consent on the 
patient’s behalf.
We used venoarterial ECMO with a centrifugal pump 
via the femoral approach with vascular exploration 
by the cut-down method. One 17-Fr arterial cannula 
was inserted into the iliac artery via the left femoral 
artery and one 19-Fr venous cannula was inserted 
through the left femoral vein and advanced into the 
inferior vena cava. The initial ECMO blood flow rate 
was 2.5 L/minute. An 8-Fr Judkins L4 guiding catheter 
(Cordis Corp., Miami, FL, USA) was used to engage 
the left coronary artery. High-speed rotational atherec-
tomy of the LCX was performed with a 1.25 mm burr, 
followed by a 1.75 mm burr. Simultaneous kissing 
balloon dilatation was then performed at the LCX 
(2.5 × 20 mm Maverick balloon; Boston Scientific 
Corp./Scimed Inc., Natick, MA, USA) at 12 atmo-
spheres (atm) and OM1 (2.0 × 20 mm Maverick balloon 
at 10 atm). A 3.5 × 23 mm Xience V (Abbott Vascular, 
Santa Clara, CA, USA) drug-eluting stent (DES) was 
deployed from OM1 to the proximal LCX. The stent 
was post-dilated with a 3.5 × 12 mm Maverick balloon 
at 18 atm, which yielded an angiographic residual ste-
nosis of < 10% (Fig. 2A). A 7-Fr Judkins R4 guiding 
catheter was then engaged at the RCA ostium. The 
RCA was crossed with a Runthrough guidewire and 
the proximal and middle lesions were predilated with 
a 2.5 × 20 mm Maverick balloon at 16 atm. Two Taxus 
(Boston Scientific Corp.) DESs were deployed sequen-
tially from the middle to the ostial segments of the RCA. 
The two stents overlapped with one 3.0 × 32 mm DES 
in the middle lesion and the other 3.5 × 24 mm DES 
in the proximal part to the ostium of the RCA. The an-
giographic result was deemed acceptable (Fig. 2B). 
The patient was weaned from ECMO immediately after 
PCI and the total support duration was 231 minutes.
The hemodynamics of the patient improved and 
the IABP was removed the next day. The angina pec-
toris and pulmonary edema improved following treat-
ment. However, the patient experienced severe ECMO 
wound infection and a plastic surgeon was consulted 
for wound management. The patient recovered well 
and was discharged 22 days after admission. Over a 
6-month follow-up period, the patient remained free 
of symptoms and did not experience any cardiovas-
cular events.
3. Discussion
The number of patients with prior CABG who have 
recurrent symptoms has been steadily increasing [1]. 
One reason is vein graft failure, which often leads to 
early coronary revascularization. The risk factors for 
repeat revascularization in patients with prior CABG 
are younger age at first operation, hypertriglyceri-
demia, lower high-density lipoprotein, diabetes mel-
litus and triple vessel disease [1]. Revascularization, 
including PCI or repeat CABG, in patients with prior 
CABG is considered a high-risk procedure.
The Society of Thoracic Surgery has reported that 
8.6–10.4% of patients require repeat CABG [2]. Our 
patient had reversible inferoposterior myocardial ische-
mia before intervention. Patients with ischemic car-
diomyopathy and viability undergoing repeat CABG 
benefit from revascularization [3]. However, repeat 
CABG is associated with a high incidence of compli-
cations. Our patient had peripheral artery occlusive 
Fig. 2 — Post-intervention coronary angiography images of: (A) left circumflex artery; (B) right coronary artery.
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disease, which indicated systemic atherosclerosis and 
a high risk of stroke. The target vessels (RCA/LCX) 
are also difficult for the surgeon to approach because 
of dense adhesion between the right atrium, right 
ventricle and the sternum. The European System for 
Cardiac Operative Risk Evaluation (EuroSCORE) is a 
scoring system for predicting operative mortality be-
fore CABG [4]. The EuroSCORE of our patient was 15 
points, indicating a predicted high operative mortal-
ity of about 55%. In recent years, minimally invasive 
surgical approaches, including mini-thoracotomies and 
beating heart techniques, have been used [5]. These 
techniques are less invasive and are effective alter-
native procedures that are often used by more expe-
rienced surgeons. Jacobs et al [5] reported 46 patients 
who underwent this surgery using the LIMA to the LAD. 
All patients had prior CABG without the use of LIMA 
and significant LAD lesions, and the outcomes were 
comparable to those using the median sternotomy 
approach. Our patient had patent LIMA to the LAD and 
was not suitable for this type of surgery. Minimally 
invasive surgery using the SVG in repeat CABG has 
been rarely reported [6]. Our patient had early vein 
graft failure, which may predict a poor outcome for 
subsequent SVG implantation. The elective surgical 
intervention for our patient was not adopted due to a 
poor operative risk-benefit ratio.
PCI is increasingly an option for patients with prior 
CABG. However, the choice of PCI for bypass graft or 
native coronary artery is dependent on the ischemic 
territories identified by a myocardial perfusion scan 
or the characteristics of coronary lesions upon CAG. 
Despite the use of bare-metal stents, PCI in patients 
with prior CABG has been associated with worse out-
come than PCI in patients without prior CABG [7]. In 
the Angina With Extremely Serious Operative Mortality 
Evaluation (AWESOME) randomized trial, Morrison et al 
[7] reported that PCI is preferable to CABG for many 
prior CABG patients with myocardial ischemia. The 
3-year survival rate difference was statistically insignifi-
cant when PCI (73%) and CABG (76%) were compared. 
Cole et al [8] reviewed the outcomes of diabetic pa-
tients with prior CABG who underwent repeat PCI or 
CABG. The inhospital mortality was less in the PCI 
group but differences in terms of long-term mortality up 
to 10 years were not significant. In a previous retrospec-
tive analysis [9], PCI was preferred in older patients 
with two-vessel CAD, patent LIMA to LAD, fewer chronic 
total occlusions, and higher LVEF. Poor LVEF, left main 
stenosis and chronic total occlusion are the major 
factors for the choice of CABG. The two SVG of our 
patient were totally occluded from the ostium, which 
implied a lower success rate and higher thromboem-
bolic risk during PCI. Consequently, we chose to per-
form PCI in the native vessels. However, the use of 
PCI is not without limitations. The incidence of sub-
sequent revascularization is higher in patients with 
prior CABG undergoing PCI than in patients with no 
prior CABG [10]. DES is effective in reducing the need 
for restenosis or repeat revascularization. Tejada et al 
[10] retrospective analyzed 91 post-CABG patients who 
underwent 197 stent implantations (84% DES) for 154 
lesions and obtained a relatively low target lesion 
revascularization (5.4%) at 1 year compared with pre-
vious studies before the DES era. One patient had late 
stent thrombosis, which was related to premature dis-
continuation of aspirin and clopidogrel. The indepen-
dent predictors of major adverse cardiac events at 
1 year for post-CABG patients who underwent PCI 
were LVEF < 50% and multivessel intervention [10].
Cardiogenic shock is a catastrophic event with a 
high mortality and the use of IABP is essential in this 
situation. Although IABP increases coronary perfusion, 
the hemodynamic support from IABP is usually insuf-
ficient [11]. ECMO can serve as a temporary rescue 
tool for patients with cardiogenic shock and provides 
full circulatory support [12–14]. However, ECMO re-
mains an invasive and expensive therapy and requires 
extensive resources. The complications of ECMO 
[15,16] include renal failure, risk of stroke, bleeding, 
hemolysis, thromboembolism, infection, vessel per-
foration and limb ischemia, all of which should never 
be overlooked. Prophylactic ECMO support is reported 
to be associated with a lower procedural mortality in 
patients with severe LV dysfunction undergoing PCI 
than standby ECMO support (4.8% vs. 18.8%, p < 0.05) 
[14]. Vainer et al [13] evaluated the effectiveness of 
ECMO in 15 patients undergoing elective high-risk PCI, 
but patients with prior CABG were not included in 
their series. The authors concluded that elective high-
risk PCI under prophylactic ECMO support was a sat-
isfactory option [13]. Our patient had only viable and 
contractile myocardium in the inferoposterior seg-
ments of the LV, and the acute closure of the LCX may 
have resulted in cardiogenic shock. ECMO support was 
reasonable in our patient based on the findings in the 
literature. However, a change in the PCI strategy may 
have avoided this complication. Since the RCA is pro-
tected by a collateral supply from the left coronary 
arteries, it would be safer to open the RCA first. If we 
had revascularized the RCA successfully, the myocar-
dium in the RCA territory would no longer need to re-
ceive a collateral supply from the LCX. Therefore, we 
would have been able to perform PCI to the LCX with 
less risk.
CABG cannot prevent the progression of athero-
sclerosis in patients with CAD. Aggressive atheroscle-
rosis risk factor reduction and the use of as many 
arterial grafts as possible at the primary CABG should 
be encouraged to secure adequate long-term results. 
Myocardial perfusion scan is required to evaluate the 
necessity of repeat revascularization. However, revas-
cularization is only beneficial if patients have revers-
ible myocardial ischemia. The selection of PCI or repeat 
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CABG is dependent on patient age, angiographic eval-
uations, LV function, and patient preference. Coronary 
lesions in patients with prior CABG are more complex 
and preclude rapid intervention; furthermore, LV func-
tion in these patients is usually poor due to multivessel 
CAD or prior myocardial infarction. PCI in such patients 
is, therefore, always associated with high risk. ECMO 
support can be applied in prior CABG patients with 
severe LV dysfunction and/or increased surgical risk 
who are undergoing PCI to vessels that supply only 
viable and contractile myocardium.
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